New research suggests that combining immunotherapies with KRAS-G12D inhibition may produce durable responses in pancreatic cancer, where immunotherapies alone have had little impact.

Authors

• Person: Not available Organization: Nature
  The breakthroughs behind UT MD Anderson's quest to end cancer

Sources

• The breakthroughs behind UT MD Anderson's quest to end cancer www.nature.com Nature via serper

Referenced by nodes (1)

• pancreatic cancer concept